PATENT CLAIM ANALYSIS

Application Number: 15919361
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "494000"]

Abstract:
Administration of a salt of bi-cyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.

Claim (Index 4):
The method of  claim 1 , wherein the bicyclo-[2.2.2]-octane-2-carboxylate salt is formulated for sustained or delayed release.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.41463
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15265983', '14232717', '15712279', '14417293', '10510459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7756370094151618
- 35 USC 102 Novelty (BERT): 0.551834170144277
- Combined Prediction Score: 0.7532567254880733
- Mean Citation Score: 226.21187200000003
- Max Citation Score: 402.2488
- Similarity Product: 399.5237475174905

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test